Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Distalmotion is a Swiss medical device company that develops a surgical robot called Dexter to establish a new standard of care.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
Twin Health is a metabolic health platform that offers sensors, AI to reverse, prevent and improve chronic metabolic diseases.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Talkiatry provides virtual mental healthcare services covered by insurance, connecting patients with licensed psychiatrists.
Perceptive Advisors has invested in 226 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 26 different industry categories.
Among tracked funding rounds, BridgeBio received $1.0B in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $30.3B.
Perceptive Advisors's average investment size is $134.2M across its portfolio of 226 companies.
Recent Perceptive Advisors portfolio additions include Rapport Therapeutics, Distalmotion, Alector, GenSight Biologics, Pyxis Oncology. These companies were founded in 2020 or later.